• SVLSF VI, LLC reported a larger stake in Trex Bio through affiliated SV Life Sciences funds.
• SV Life Sciences Fund VI, L.P. bought 89,783 shares at $14, lifting its holding to 214,869 shares.
• Preferred stock converted into common stock, raising SV Life Sciences Fund VI, L.P.’s position to 2,264,354 shares.
• SV Life Sciences Fund VI Strategic Partners, L.P. added shares at $14, then rose to 77,525 shares following conversions.
• SV Trex Coinvestment, L.P. held 669,939 shares following preferred-to-common conversion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trex Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-011084), on October 13, 2026, and is solely responsible for the information contained therein.